Other OTC - Delayed Quote USD

NP Life Sciences Health Industry Group Inc. (NPLS)

0.3650 0.0000 (0.00%)
At close: May 7 at 11:34 AM EDT
Loading Chart for NPLS
DELL
  • Previous Close 0.3650
  • Open 0.3650
  • Bid --
  • Ask --
  • Day's Range 0.3650 - 0.3650
  • 52 Week Range 0.3000 - 0.6500
  • Volume 400
  • Avg. Volume 92
  • Market Cap (intraday) 15.68M
  • Beta (5Y Monthly) 1.40
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Apr 16, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NP Life Sciences Health Industry Group Inc. provides educational and other related services based on classical Chinese studies and culture. The company offers international study tours, which include the youth study tour series, adult study tour series, and themed study tour series of culture and art. It also provides lectures on classical studies; meditation courses; education and training services, such as beginner, mid-level and premium classes; and cultural events and art exhibitions. In addition, the company offers consulting and planning services to its contracted Chinese partners, including telephone or online consultation regarding market and research analysis of classical Chinese culture study in the United States for the business activities or international tour proposed by its Chinese partners, as well as online oral trainings to the staff of its Chinese business partners. It serves the Chinese-Americans, American youths, scholars, art collectors, and professional and corporate executives interested in learning about Chinese culture. The company was formerly known as GJ Culture Group US, Inc. and changed its name to NP Life Sciences Health Industry Group Inc. in November 2022. NP Life Sciences Health Industry Group Inc. was incorporated in 2018 and is based in Danville, California.

www.gjcc.us

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NPLS

Performance Overview: NPLS

Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NPLS
33.64%
S&P 500
9.49%

1-Year Return

NPLS
28.43%
S&P 500
26.79%

3-Year Return

NPLS
28.43%
S&P 500
23.39%

5-Year Return

NPLS
--
S&P 500
51.23%

Compare To: NPLS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NPLS

Valuation Measures

Annual
As of 5/10/2024
  • Market Cap

    15.68M

  • Enterprise Value

    15.63M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    95.25

  • Price/Book (mrq)

    957.22

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.78%

  • Return on Assets (ttm)

    -0.42%

  • Return on Equity (ttm)

    -16.44%

  • Revenue (ttm)

    164.62k

  • Net Income Avi to Common (ttm)

    -2.94k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    70.61k

  • Total Debt/Equity (mrq)

    136.51%

  • Levered Free Cash Flow (ttm)

    -71.51k

Research Analysis: NPLS

Company Insights: NPLS

Research Reports: NPLS

People Also Watch